12 unknown. 12 Phase 1, 8 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 12 | Unknown 12 |
| Phase 2 | 8 | Unknown 8 |
Follow Osteosarcoma: new trials by email Literature Review of Osteosarcoma trials Research Report on Osteosarcoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| IM83 Clinical Study of CAR-T Cell Therapy in Patients With Relapsed or Refractory Osteosarcoma IM83 CAR-T Cells - Refractory Osteosarcoma, Recurrent Osteosarcoma | Phase 1 | Unknown | Beijing Immunochina Medical Science & Technology Co., Ltd. | 9 | 2024-06-15 | 2024-05-14 |
| A Rollover Protocol to Allow for Continued Access to the LSD1 Inhibitor Seclidemstat (SP-2577) Seclidemstat - Ewing Sarcoma, Myxoid Liposarcoma | Phase 1 / Phase 2 | Unknown | Salarius Pharmaceuticals, LLC | 10 | 2022-01-15 | 2023-08-01 |
| A Study to Evaluate the Safety and Efficacy of ALMB-0168 in Patients With Osteosarcoma ALMB-0168 - Osteosarcoma | Phase 1 / Phase 2 | Unknown | AlaMab Therapeutics (Shanghai) Inc. | 238 | 2021-05-01 | 2021-05-14 |
| TQB3525 for Advanced Bone Sarcomas With PI3KA Mutations or PTEN Loss TQB3525 - Safety Issues, Efficacy, Self | Phase 1 / Phase 2 | Unknown | Peking University People's Hospital | 29 | 2020-10-01 | 2020-12-31 |
| A Phase I Clinical Trial of Neoadjuvant Chemotherapy With/Without SPIONs/SMF for Patients With Osteosarcoma neoadjuvant chemotherapy+SPIONs/SMF, neoadjuvant chemotherapy - Osteosarcoma | Phase 1 | Unknown | Second Affiliated Hospital, Zhejiang University, School of Medicine | 60 | 2020-09-01 | 2020-03-20 |
| A Clinical Study of PD-L1 Antibody ZKAB001(Drug Code) in Limited Stage of High-grade Osteosarcoma ZKAB001 5mg/kg, ZKAB001 10mg/kg, ZKAB001 15mg/kg - Osteosarcoma | Phase 1 / Phase 2 | Unknown | Lee's Pharmaceutical Limited | 15 | 2018-10-10 | 2018-09-26 |
| Clinical Trial of SP-2577 (Seclidemstat) in Patients With Relapsed or Refractory Ewing or Ewing-related Sarcomas Seclidemstat, Cyclophosphamide, Topotecan - Ewing Sarcoma, Myxoid Liposarcoma | Phase 1 | Unknown | Salarius Pharmaceuticals, LLC | 50 | 2018-06-04 | 2023-11-21 |
| Anlotinib and Irinotecan for Ewing Sarcoma Anlotinib, Irinotecan - Ewing's Tumor Metastatic | Phase 1 / Phase 2 | Unknown | Peking University People's Hospital | 47 | 2018-01-22 | 2019-02-15 |
| Pilot Study of Expanded , Activated Haploidentical Natural Killer Cell Infusions for Sarcomas Expanded , Activated NK cells - Ewing Sarcoma, Rhabdomyosarcoma | Phase 1 / Phase 2 | Unknown | National University Hospital, Singapore | 20 | 2015-02-01 | 2019-04-16 |
| Pilot Study of Curcumin Formulation and Ashwagandha Extract in Advanced Osteosarcoma Curcumin powder, Ashwagandha extract - Osteosarcoma | Phase 1 / Phase 2 | Unknown | Tata Memorial Hospital | 24 | 2008-05-01 | 2011-06-23 |
| Safety Study of Seneca Valley Virus in Patients With Solid Tumors With Neuroendocrine Features Seneca Valley Virus (biological agent) - Carcinoid, Neuroendocrine | Phase 1 | Unknown | Neotropix | 60 | 2006-04-01 | 2010-02-25 |
| Tandem Peripheral Blood Stem Cell (PBSC) Rescue for High Risk Solid Tumors High-Dose Chemotherapy with Tandem PBSC Rescue. - Ewing's Sarcoma, Soft Tissue Sarcoma | Phase 1 / Phase 2 | Unknown | Ann & Robert H Lurie Children's Hospital of Chicago | 12 | 1999-04-01 | 2010-10-11 |
Sarcoma, Ewing (7) · Chondrosarcoma, Extraskeletal Myxoid (2) · Desmoplastic Small Round Cell Tumor (2) · Histiocytoma, Angiomatoid Fibrous (2) · Liposarcoma, Myxoid (2) · Myoepithelioma (2) · Rhabdomyosarcoma (2) · Sarcoma (2) · Sarcoma, Clear Cell (2) · Wilms Tumor (2) · Carcinoid Tumor (1) · Chondrosarcoma (1) · Fibroma (1) · Glioblastoma (1)
Neoplasms (12) · Neoplasms by Histologic Type (12) · Neoplasms, Bone Tissue (12) · Neoplasms, Connective Tissue (12) · Neoplasms, Connective and Soft Tissue (12) · Sarcoma (10) · Neoplasms, Complex and Mixed (4) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Genetic Diseases, Inborn (2) · Kidney Diseases (2) · Kidney Neoplasms (2) · Liposarcoma (2)
Cyclophosphamide (3) · Topotecan (2) · seclidemstat (2) · Ashwagandha (1) · Biological Factors (1) · Drug Therapy (1) · Irinotecan (1) · Neoadjuvant Therapy (1) · TQ-B3525 (1) · anlotinib (1)
Peking University People's Hospital (2) · Salarius Pharmaceuticals, LLC (2) · AlaMab Therapeutics (Shanghai) Inc. (1) · Ann & Robert H Lurie Children's Hospital of Chicago (1) · Beijing Immunochina Medical Science & Technology Co., Ltd. (1) · Lee's Pharmaceutical Limited (1) · National University Hospital, Singapore (1) · Neotropix (1) · Second Affiliated Hospital, Zhejiang University, School of Medicine (1) · Tata Memorial Hospital (1)
China (4) · United States (4) · India (1) · Singapore (1)
Bernice Oh (1) · Dario Campana (1) · Jingnan Shen, Doctor (1) · Morris Kletzel, M.D. (1) · Rudin Charles, MD, PhD (1) · Wei Guo, M.D, Ph.D (1) · Wei Guo, Ph.D and M.D. (1) · Yu Zhang, PhD (1)